A report by the European Heart for Illness Prevention and Management states that the variety of reported circumstances of two extremely drug-resistant pathogens elevated in 2020, the primary yr of the COVID-19 pandemic, after which elevated sharply in 2021.
The surge was pushed by outbreaks in intensive care items in international locations the place antimicrobial-resistant infections had been already widespread.
Some scientists have linked the rise in hospital-acquired superbug infections in the course of the pandemic to the elevated prescription of antibiotics to deal with COVID-19 and different bacterial infections throughout prolonged hospital stays.
Drug resistance develops because of misuse or overuse of antibiotics. Consultants name superbacterial infections, together with fungal pathogens, a silent pandemic that causes greater than 1,000,000 deaths every year however doesn’t appeal to consideration or analysis funding.